Bennett Watson | Westwicke, Investor Relations |
Dan Barber | Chief Executive Officer |
Ernie Toth | Senior Vice President, Chief Financial Officer |
Ken Truitt | Chief Medical Officer |
Ken Marshall | Chief Commercial Officer |
Steve Wargacki | Head of R&D |
Dennis Resnick | BMO |
Jason Butler | JMP Securities |
Francois Brisebois | Oppenheimer |
Thomas Flaten | Lake Street Capital Markets |
Andreas Argyrides | Wedbush |
Laura Searle | Alliance |
Good morning, and welcome to the Aquestive Therapeutics Third Quarter 2022 Conference Call. At this time, all participants are in a listen only-mode. After the speakers' remarks, there will be a question-and-answer session. Instructions will be given at that time.
As a reminder, this call will be recorded.